Wide-Moat Stocks: Companies Dominating Their Markets
Warren Buffett popularized the concept of an economic moat — a durable competitive advantage that protects a company’s profits and market share from rivals over time, much like the water surrounding a medieval castle protected its inhabitants. Morningstar later formalized the idea into a three-tier rating system: wide moat (advantages expected to last 20+ years), narrow moat (at least 10 years), and no moat.
Morningstar identifies five sources from which a moat can be derived:
- Network effect: The product becomes more valuable as more people use it — Visa, Mastercard, and Meta are classic examples.
- Intangible assets: Patents, brands, and regulatory licenses that block competitors — Coca-Cola’s brand power and Moody’s regulatory standing fall here.
- Switching costs: Customers face high costs or friction when changing providers — Microsoft’s enterprise software suite is a textbook case.
- Cost advantage: Structural cost efficiencies that competitors cannot replicate — Waste Management’s vertically integrated network of landfills, recycling centers, and exclusive municipal licenses is nearly impossible for new entrants to match.
- Efficient scale: Markets that naturally support only one or a few players — Union Pacific in railroads and ASML in extreme ultraviolet lithography, where it holds a near-monopoly on EUV systems essential for producing the most advanced semiconductor chips.
Wide-moat companies cluster heavily in technology, healthcare, consumer staples, financials, and industrials. Six of the Magnificent Seven — Nvidia, Meta Platforms, Apple, Amazon, Microsoft, and Alphabet — carry wide-moat designations. Beyond tech, names like LVMH, Novo Nordisk, and Ferrari maintain advantages rooted in heritage, patents, and exclusivity that competitors simply cannot replicate.
For those interested in a fund-based approach, the VanEck Morningstar Wide Moat ETF (MOAT) tracks the Morningstar Wide Moat Focus Index, which selects attractively priced companies with wide-moat ratings and rebalances quarterly across two staggered sub-portfolios of 40 stocks each.
Regulated brokerThe table below lists companies with unrivalled economic moats — businesses with dominant, hard-to-replicate market positions. All data including price and market cap are updated regularly.
| Stock | Price | Change % | Marketcap |
|---|---|---|---|
Gilead Sciences GILD | $150.11 | 0.52% | 186.13B |
Boeing BA | $198.20 | 0.61% | 156.65B |
GE HealthCare Technologies GEHC | $64.13 | 0.49% | 28.97B |
Walt Disney DIS | $102.67 | 2.54% | 177.28B |
Corteva CTVA | $80.53 | 1.23% | 53.73B |
Bristol-Myers Squibb BMY | $63.06 | 0.35% | 128.81B |
Alphabet (Google) GOOG | $344.41 | 0.21% | 4.21T |
Veeva Systems VEEV | $260.21 | 1.34% | 42.13B |
Altria Group MO | $69.52 | 0.26% | 116.08B |
TransUnion TRU | $72.43 | 0.93% | 13.88B |
U.S. Bancorp USB | $60.06 | 0.32% | 93.58B |
Agilent Technologies A | $156.47 | 0.08% | 44.12B |
NXP Semiconductors NXPI | $227.99 | 0.02% | 57.49B |
Allegion ALLE | $152.28 | 0.88% | 12.95B |
Kenvue KVUE | $17.81 | 0.34% | 34.21B |
Zimmer Biomet ZBH | $95.36 | 1.18% | 18.19B |
Pfizer PFE | $27.66 | 0.07% | 157.65B |
Bio-Rad Laboratories BIO | $376.41 | 1.57% | 10.06B |
Nike NKE | $35.51 | 2.34% | 52.68B |
International Flavors & Fragrances IFF | $82.96 | 1.83% | 21.17B |
United Parcel Service UPS | $99.06 | 1.11% | 84.28B |
Teradyne TER | $371.47 | 5.19% | 58.08B |
Estee Lauder EL | $93.43 | 0.46% | 33.80B |
Campbell Soup CPB | $20.69 | 2.31% | 6.17B |
Adobe ADBE | $248.92 | 1.48% | 98.95B |
Microchip Technology MCHP | $73.27 | 3.46% | 39.79B |
MarketAxess MKTX | $163.42 | 0.06% | 5.75B |
Huntington Ingalls Industries HII | $272.86 | 1.54% | 10.75B |
Brown Forman Inc BF-B | $25.94 | 2.11% | 11.90B |
Salesforce CRM | $237.92 | 2.03% | 195.81B |
Charles Schwab SCHW | $105.25 | 0.59% | 182.01B |
Emerson EMR | $149.92 | 1.71% | 83.63B |
Amazon AMZN | $253.71 | 1.00% | 2.74T |
Monolithic Power Systems MPWR | $1,217.80 | 4.12% | 59.85B |
Autodesk ADSK | $216.95 | 0.77% | 45.34B |
Air Products and Chemicals APD | $284.18 | 0.68% | 63.28B |
Amgen AMGN | $385.65 | 1.55% | 208.49B |
Otis Worldwide OTIS | $68.52 | 0.26% | 26.08B |
Thermo Fisher Scientific TMO | $651.45 | 1.04% | 240.87B |
Lam Research LRCX | $288.11 | 6.98% | 360.52B |
Masco MAS | $68.06 | 0.25% | 13.42B |
Mondelez MDLZ | $60.85 | 1.92% | 77.66B |
Honeywell HON | $206.46 | 0.01% | 65.44B |
Northrop Grumman NOC | $527.39 | 0.65% | 74.92B |
Equifax EFX | $158.87 | 1.43% | 18.66B |
IDEX IEX | $223.72 | 0.82% | 16.49B |
Microsoft MSFT | $493.78 | 0.80% | 3.67T |
Danaher DHR | $211.81 | 0.32% | 148.90B |
Merck MRK | $146.87 | 0.19% | 362.35B |
Constellation Brands STZ | $118.97 | 2.84% | 20.32B |
West Pharmaceutical WST | $362.31 | 1.17% | 25.50B |
Apple AAPL | $336.13 | 0.26% | 4.91T |
